论文信息 - Unbiased screening reveals that blocking exportin 1 overcomes resistance to PI3Kα inhibition in breast cancer - 字舞流文

Unbiased screening reveals that blocking exportin 1 overcomes resistance to PI3Kα inhibition in breast cancer

Qiao-jun He | Linghua Meng | Xi Zhang | Cun Tan | Chun-hao Yang | Yi Wang | Yu-xiang Wang | Xue-ling Liu | Bo-bo Wang | Jian Ding

[1] Q. Zhan,et al. PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment. , 2019, Cancer letters.

[2] A. Markham. Alpelisib: First Global Approval , 2019, Drugs.

[3] Yi Chen,et al. Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer , 2019, Cancer biology & medicine.

[4] Yi Chen,et al. Decrease in phosphorylated ERK indicates the therapeutic efficacy of a clinical PI3Kα-selective inhibitor CYH33 in breast cancer. , 2018, Cancer letters.

[5] L. Garraway,et al. Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer. , 2016, Cancer discovery.

[6] Angela Tam,et al. AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas. , 2015, Cancer cell.

[7] Obi L. Griffith,et al. Convergent loss of PTEN leads to clinical resistance to a PI3Kα inhibitor , 2014, Nature.

[8] Kaushal Parikh,et al. Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents , 2014, Journal of Hematology & Oncology.

[9] E. Baloglu,et al. Clinical translation of nuclear export inhibitors in cancer. , 2014, Seminars in cancer biology.

[10] J. Lehár,et al. CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors. , 2014, Cancer cell.